A61K 49 - Preparations for testing in vivo

Patents for A61K 49 - Preparations for testing in vivo (35,376)
12/1997
12/23/1997	US5700448 Contrast media
12/23/1997	US5700444 Metallopeptide for drug delivery, diagnosis, treating infections, inflammations, diseases
12/18/1997	WO1997047971A1 Methods and compositions for the use of apurinic/apyrimidinic endonucleases
12/18/1997	WO1997047637A1 Phosphotriester oligonucleotides, amidites and method of preparation
12/18/1997	WO1997047327A1 Compounds that interfere with dna replication in rapidly proliferating cells for use in cancer therapy and methods for screening for such compounds
12/18/1997	WO1997047322A1 Medical powder
12/18/1997	WO1997030736A3 Contrast medium
12/18/1997	CA2258092A1 Medical powder
12/18/1997	CA2251575A1 Compounds that interfere with dna replication in rapidly proliferating cells for use in cancer therapy and methods for screening for such compounds
12/17/1997	EP0812594A1 Compounds that interfere with DNA replication in rapidly proliferating cells for use in cancer therapy and methods for screening for such compounds
12/17/1997	EP0812422A1 Process and compounds for use in detecting analytes by measurement of residual magnetism, and the use of the said compounds
12/17/1997	EP0812333A1 Bispecific antibody effective to treat b-cell lymphoma and cell line
12/17/1997	EP0812332A1 AN IMMUNOINTERACTIVE MOLECULE WHICH BINDS THE $i(TIE)2/TEK RECEPTOR EXTRACELLULAR DOMAIN
12/17/1997	EP0812214A1 Stabilized gas emulsion containing phospholipid for ultrasound contrast enhancement
12/17/1997	EP0812151A1 Method and apparatus for magnetic resonance imaging of arteries using a magnetic resonance contrast agent
12/17/1997	CN1167639A Magnetic resonance contrast medium for gastrointestinal tract
12/17/1997	CN1036717C Polyazamacrocyclic compounds for complexation of metal ions
12/16/1997	US5698739 Carboxamide non-ionic contrast media
12/16/1997	US5698581 Substituted N-heteroaroylguanidines, a process for their preparation, their use as a medicament or diagnostic agent, and a medicament containing them
12/16/1997	US5698413 Method of evaluating chemotherapeutic agents in vivo
12/16/1997	US5698405 Coupling immunogenic agent with a carbohydrate polymer
12/16/1997	US5697902 Treating patient with antibody or antibody fragment conjugated to cytotoxic agent
12/11/1997	WO1997046669A1 Transgenic mammals lacking expression of amylin
12/11/1997	WO1997046664A1 Perlecan transgenic animals and methods of identifying compounds for the treatment of amyloidoses
12/11/1997	WO1997046572A1 Transgenic animals expressing artificial epitope-tagged proteins
12/11/1997	WO1997046264A2 Pressure resistant protein microspheres as ultrasonic imaging agents
12/11/1997	WO1997046262A2 Membrane incorporation of texaphyrins
12/11/1997	WO1997026920A3 Conjugate for differentiating between diseased and healthy tissues
12/11/1997	WO1997020841A3 New macrobicyclic compounds, methods of preparing them and pharmaceutical agents containing them
12/11/1997	CA2257225A1 Membrane incorporation of texaphyrins
12/11/1997	CA2253734A1 Pressure resistant protein microspheres as ultrasonic imaging agents
12/11/1997	CA2253262A1 Transgenic animals expressing artificial epitope-tagged proteins
12/10/1997	EP0811382A1 Mammography method
12/10/1997	EP0810990A1 Substituted dtpa monoamides of central carboxylic acids and metal complexes thereof, pharmaceuticals containing these complexes, diagnostic and therapeutic uses thereof and methods for preparing the complexes and pharmaceuticals
12/10/1997	EP0810989A1 Novelly substituted dtpa derivatives, metal complexes thereof, pharmaceuticals containing these complexes, diagnostic and therapeutic uses thereof and methods for preparing the complexes and pharmaceuticals
12/10/1997	EP0810883A2 Individual medicament dosing conjugate
12/10/1997	EP0810853A1 Aerosols containing nanoparticle dispersions
12/10/1997	EP0570575B1 Bicycloazamacrocyclophosphonic acid, conjugates, contrast agents and preparation
12/10/1997	EP0531421B1 Contrast media for ultrasonic imaging
12/10/1997	EP0440744B1 Products and methods for controlling the suppression of the neoplastic phenotype
12/10/1997	CN1167444A Use of metal complexes as liver and gall bladder radiodiagnosis agent in CT scanning
12/10/1997	CN1167443A Use of metal complexes as liver and gall bladder radiodiagnosis agents in computer tomography
12/10/1997	CN1166987A Magnetic resonance imaging contrast medium of paramagnetism metal compound containing D-galactose group
12/10/1997	CN1036634C Method for preparing sodium alginate couplant for ultrasonic diagnostic instrument
12/09/1997	US5696104 Topically applying to skin of mammal active ligand for member of steroidal/thyroidal receptors, administering topically or systemically molecule to be tested, evaluating skin response
12/09/1997	US5695934 Massively parallel sequencing of sorted polynucleotides
12/09/1997	US5695932 Telomerase activity assays for diagnosing pathogenic infections
12/09/1997	US5695931 Nucleotide sequences coding for a protein with urease activity
12/09/1997	US5695742 Aqueous injectable formulations useful for radiodiagnosis comprising iodinated aromatic compounds used as X-ray contrast media
12/09/1997	US5695741 Fluorocarbon gas osmotic agent dispersed in controlled diameter spray dried microspheres containing mixture of surfactant with starch(es), dextran, and sugar esters, also having controlled hydrophilic-lipophilic balance
12/09/1997	US5695740 Perfluorocarbon ultrasound contrast agent comprising microbubbles containing a filmogenic protein and a saccharide
12/09/1997	US5695739 Nuclear magnetic resonance imaging agents
12/09/1997	US5695737 Dimeric DTPA derivatives, their metal complexes and pharmaceutical agents containing these complexes
12/09/1997	US5695480 Embolizing compositions
12/09/1997	US5694950 Method and system for use in treating a patient with immunosuppresants using whole blood level criteria to prevent an adverse immune response
12/04/1997	WO1997045145A2 A diagnostic test for schizophrenia, using niacin
12/04/1997	CA2256394A1 A diagnostic test for schizophrenia, using niacin
12/03/1997	EP0809701A1 Calcineurin regulatable adenylate cyclase
12/03/1997	EP0809519A1 Compositions comprising tricodobenzene polymers for imaging the gastrointestinal tract
12/03/1997	EP0809500A1 Novel glucocorticoid response elements
12/03/1997	EP0797433A4 Gas filled microspheres as magnetic resonance imaging contrast agents
12/03/1997	EP0627939B1 Conjugates of biotin and deferoxamine for radioimmunoimaging and radioimmunotherapy
12/03/1997	CN1166826A Iodinated X-ray contrast media
12/02/1997	US5693776 Nucleic acids specific for Rochalimaea quintana
12/02/1997	US5693775 Fibroblast growth factor homologous factor-1 (FHF-1) and methods of use
12/02/1997	US5693763 Antibodies to human carcinoma antigen
12/02/1997	US5693321 Polymers containing diester units
12/02/1997	US5693311 Polyiodinated compounds, process for preparing them and diagnostic compositions
12/02/1997	US5693310 Amide complexes
12/02/1997	US5693309 Substituted complexing agents, complexes, and complex salts, processes for their production, and pharmaceuticals containing same
12/02/1997	US5693308 A rare earth complex containing mercapto or disulfide groups capable of reversibly binding to thiol groups of blood-borne proteins; increased residence time
11/1997
11/27/1997	WO1997044460A1 Modulators of tissue regeneration
11/27/1997	WO1997044067A2 Use of hollow microcapsules
11/27/1997	WO1997044066A1 A method of evaluating an effect of a substance applied to the skin of a mammal
11/27/1997	WO1997032572A3 Materials and methods for enhancing cellular internalization
11/27/1997	DE19621061A1 Ultrasound contact and coupling gel
11/27/1997	CA2496906A1 Ret ligand (retl) for stimulating neural and renal growth
11/27/1997	CA2251937A1 Use of hollow microcapsules
11/26/1997	EP0808175A1 Contrast media for in vivo imaging based on light transmission on reflection
11/26/1997	EP0808155A1 Sugar base surfactant for nanocrystals
11/26/1997	EP0808125A1 Calcium/oxyanion-containing particles for use in medical diagnostic imaging
11/26/1997	EP0466816B1 Method for enhancing transmembrane transport of exogenous molecules
11/26/1997	CN1036501C Solid reagent for pencillin skin test and its prodn. method
11/25/1997	US5691318 Nervous system disorders and medical diagnosis
11/25/1997	US5691306 Protein secretion
11/25/1997	US5690909 Fluorine-containing macrocyclic metal complexes
11/25/1997	US5690908 Magnetic resonance imaging
11/25/1997	US5690907 Ultrasonic and magnetic resonance imaging; x-rays, tomography
11/25/1997	US5690905 Peptide-metal ion pharmaceutical labeling method
11/20/1997	WO1997043293A1 Contrast agents
11/20/1997	WO1997043285A1 Tropane derivatives useable in particular for in vivo detection of dopamine transporters
11/20/1997	WO1997042978A1 Δ1,2bicyclo[4,4,0] functional dyes for contrast enhancement in optical imaging
11/20/1997	WO1997042977A1 Δ1,6 bicyclo [4,4,0] functional dyes for contrast enhancement in optical imaging
11/20/1997	WO1997042976A1 Tricyclic functional dyes for contrast enhancement in optical imaging
11/20/1997	WO1997042951A1 Methods of identifying modulators of perivascular sensory nerve ca2+ receptors
11/20/1997	WO1997026017A3 Perfluoroalkyl-containing metal complexes and their use in nmr diagnostics
11/20/1997	CA2254900A1 .delta.1,6 bicyclo ¬4,4,0\| functional dyes for contrast enhancement in optical imaging
11/20/1997	CA2254089A1 Tropane derivatives useable in particular for in vivo detection of dopamine transporters
11/20/1997	CA2253307A1 Contrast agents
11/19/1997	EP0807683A2 Endothelial cell-leukocyte adhesion molecules (ELAMs) and molecules involved in leukocyte adhesion (MILAs)

1 ... 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 ... 354